BlackRock’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $475M | Sell |
|
|||||
|
2025
Q2 | $425M | Sell |
|
|||||
|
2025
Q1 | $492M | Buy |
|
|||||
|
2024
Q4 | $661M | Buy |
|
|||||
|
2024
Q3 | $646M | Buy |
|
|||||
|
2024
Q2 | $423M | Buy |
|
|||||
|
2024
Q1 | $512M | Buy |
|
|||||
|
2023
Q4 | $473M | Buy |
|
|||||
|
2023
Q3 | $515M | Sell |
|
|||||
|
2023
Q2 | $598M | Sell |
|
|||||
|
2023
Q1 | $766M | Buy |
|
|||||
|
2022
Q4 | $665M | Sell |
|
|||||
|
2022
Q3 | $662M | Sell |
|
|||||
|
2022
Q2 | $787M | Sell |
|
|||||
|
2022
Q1 | $991M | Sell |
|
|||||
|
2021
Q4 | $1.34B | Buy |
|
|||||
|
2021
Q3 | $1.31B | Sell |
|
|||||
|
2021
Q2 | $1.18B | Sell |
|
|||||
|
2021
Q1 | $1.09B | Buy |
|
|||||
|
2020
Q4 | $1.1B | Buy |
|
|||||
|
2020
Q3 | $836M | Buy |
|
|||||
|
2020
Q2 | $714M | Sell |
|
|||||
|
2020
Q1 | $784M | Sell |
|
|||||
|
2019
Q4 | $858M | Buy |
|
|||||
|
2019
Q3 | $698M | Buy |
|
|||||
|
2019
Q2 | $610M | Buy |
|
|||||
|
2019
Q1 | $590M | Sell |
|
|||||
|
2018
Q4 | $450M | Buy |
|
|||||
|
2018
Q3 | $585M | Buy |
|
|||||
|
2018
Q2 | $537M | Buy |
|
|||||
|
2018
Q1 | $458M | Buy |
|
|||||
|
2017
Q4 | $424M | Buy |
|
|||||
|
2017
Q3 | $376M | Sell |
|
|||||
|
2017
Q2 | $393M | Buy |
|
|||||
|
2017
Q1 | $345M | Buy |
|
|||||
|
2016
Q4 | $3.14M | Sell |
|
|||||
|
2016
Q3 | $2.85M | Buy |
|
|||||
|
2016
Q2 | $2.11M | Sell |
|
|||||
|
2016
Q1 | $3.17M | Buy |
|
|||||
|
2015
Q4 | $2.96M | Sell |
|
|||||
|
2015
Q3 | $3.57M | Buy |
|
|||||
|
2015
Q2 | $2.87M | Buy |
|
|||||
|
2015
Q1 | $958K | Buy |
|
|||||
|
2014
Q4 | $118K | Hold |
|
|||||
|
2014
Q3 | $111K | Hold |
|
|||||
|
2014
Q2 | $117K | Sell |
|
|||||
|
2014
Q1 | $193K | Sell |
|
|||||
|
2013
Q4 | $349K | Buy |
|
|||||
|
2013
Q3 | $331K | Buy |
|
|||||
|
2013
Q2 | $309K | Buy |
|